Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
Gene flow from North Africa contributes to differential human genetic diversity in southern Europe.
FDA reversal sends mixed message to multiple sclerosis community.
A single-nucleotide polymorphism in serine-threonine kinase 11, the gene encoding liver kinase b1, is a risk factor for multiple sclerosis.
Celastrol Ameliorates EAE Induction by Suppressing Pathogenic T Cell Responses in the Peripheral and Central Nervous Systems.
Isolated dysphagia due to aquaporin-4 autoimmunity.
The Retinal Nerve Fiber Layer of Patients With Neuromyelitis Optica and Chronic Relapsing Optic Neuritis is More Severely Damaged than Patients With Multiple Sclerosis.
Tryptophan metabolite analog, N-(3,4-dimethoxycinnamonyl) anthranilic acid, ameliorates acute graft-versus-host disease through regulating T cell proliferation and polarization.
Healthcare provider beliefs about exercise and fatigue in people with multiple sclerosis.
Muscle-specific kinase antibody positive myaesthenia gravis and multiple sclerosis co-presentation: A case report and literature review.
Global and 3D Spatial Assessment of Neuroinflammation in Rodent Models of Multiple Sclerosis.
Bridging, switching or drug holidays - how to treat a patient who stops natalizumab?
Predicting falls in people with multiple sclerosis: fall history is as accurate as more complex measures.
Is neuropsychological rehabilitation effective in multiple sclerosis?
Molecular mechanisms of scar-sourced axon growth inhibitors.
Overview of the management of relapsing-remitting multiple sclerosis and practical recommendations.
Endocannabinoids and the Immune System in Health and Disease.
Autoimmune thyroiditis associated with neuromyelitis optica (NMO).
Remyelination Therapy in Multiple Sclerosis.
Elevated Nuclear and Cytoplasmic FTY720-Phosphate in Mouse Embryonic Fibroblasts Suggests the Potential for Multiple Mechanisms in FTY720-Induced Neural Tube Defects.
Validation of the Serbian Version of Multiple Sclerosis Spasticity Scale 88 (MSSS-88).
Perception of Pain Self-efficacy and Fatigue in Greek Patients with Multiple Sclerosis: A Study Protocol.
Disease activity return after natalizumab cessation in multiple sclerosis.
Clinical response and tolerability of fampridine in clinical practice.
The pathological and physiological roles of IL-6 amplifier activation.
Pages
« first
‹ previous
…
595
596
597
598
599
600
601
602
603
…
next ›
last »